Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models
about
Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Investigation of the In Vitro ...... e cancer cell and tumor models
@ast
Investigation of the In Vitro ...... e cancer cell and tumor models
@en
type
label
Investigation of the In Vitro ...... e cancer cell and tumor models
@ast
Investigation of the In Vitro ...... e cancer cell and tumor models
@en
prefLabel
Investigation of the In Vitro ...... e cancer cell and tumor models
@ast
Investigation of the In Vitro ...... e cancer cell and tumor models
@en
P2093
P2860
P1433
P1476
Investigation of the In Vitro ...... e cancer cell and tumor models
@en
P2093
Bertrand Neveu
Donald Poirier
Frédéric Pouliot
Lucie Carolle Kenmogne
René Maltais
P2860
P304
P356
10.1371/JOURNAL.PONE.0171871
P407
P50
P577
2017-02-09T00:00:00Z